1) A project looking at microbial metabolites as disease-modifying factors in #LongCovid.
2) A project to unravel the pathophysiology of post-exertional malaise (PEM) in Long COVID and ME/CFS, including looking at blood and muscle biomarkers.
2/
3) A grant to characterize non-restorative sleep in post-viral disease.
4) A project to look at the impact of surgery for stenosis on ME/CFS symptoms. #MESpine
5) A project to look at altered T cell responses in #LongCovid and ME/CFS, including T cell exhaustion.
3/
6) A deep learning/computational modeling project to identify drugs to repurpose for #LongCovid.
7) A project on microclots, analyzing microclot burden in patients over time and looking at the impact of infection & vaccination on microclot levels.
4/
8) A deep dive into multi-omic profiling of #LongCovid.
9) A clinical trial on Low Dose Naltrexone (LDN).
5/
This fund and awarded projects are distinctly meaningful for four major reasons:
1st: A panel of 15 patient researchers with #LongCovid, ME/CFS, & dysautonomia decided how the $4.8m in research funding should be allocated
including calling for specific areas of research in the RFP.
This is a change from the typical power dynamic of biomedical research, especially in chronic illness, where large organizations decide where funding should go, and patients have no input into what is studied. 7/
2nd: #LongCovid research has fallen short of its promise to improve patient health & has largely disregarded decades of research into infection-associated illnesses. The awarded projects have an emphasis on impact & are well informed by existing research. 8/
3rd: these projects showcase the many investigative paths that #LongCovid & ME/CFS patients would like to see pursued, including microclots, spinal-structural abnormalities, immunologic dysfunction, microbiome changes, sleep dysfunction, drug repurposing, and a clinical trial. 9/
4th: Each project that doesn’t already have patient representatives on the project will receive 1-2 paid patient representatives from PLRC to inform study design. This will ensure that the lived experience of patients are incorporated in all steps of the research process. 10/
We hope the #LongCovid, #pwME, dysautonomia, and #NEISVoid communities are happy with these decisions, and look forward to sharing the research results as they come out! 11/
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Dr. Iwasaki explains that SARS-Cov2 is “one of many unexplained post-acute infection syndromes [that]
occur after encounter with many distinct pathogens” (such as EBV, polio, & dengue). @NIH#LongCovid#LongCovidKids
Dr. Iwasaki says that COVID-19 can cause long-lasting symptoms involving almost all organs and cites @patientled research on symptomology of #LongCovid. @NIH#CovidIsNotOver
Dr. Bateman speaks of a case study: an identical twin female, 17years, track athlete, who developed severe exhaustion affecting every area of her life. She was able to attend college, but never able to work full-time. #MECFS
At age 24, she suffered an infection and was erroneously diagnosed with a psychiatric disorder. She was seen by Dr. Bateman, who tested for and diagnosed dysautonomia. The patient was able to be upright for 1 hour on worst days. Pyridostigmine was a beneficial therapeutic. #MECFS